查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1918107

流式細胞技術市場－2026-2031年預測

Flow Cytometry Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計流式細胞技術市場將從 2025 年的 61.96 億美元成長到 2031 年的 94.79 億美元，複合年成長率為 7.34%。

由於流式細胞技術市場正經歷顯著擴張。該技術能夠快速分析單一細胞的物理和化學特性，使其成為從免疫表現型分析到細胞分級分離等多種應用的必備工具。市場成長的促進因素包括某些疾病盛行率的上升、技術的不斷進步以及政府機構和研究機構的大力支持。

流式細胞技術廣泛而多樣的應用是市場成長的關鍵促進因素。此技術可用於分析多種檢體，包括骨髓、全血和固態組織。其功能涵蓋免疫表現型分析、利用螢光染料進行DNA/RNA含量分析、異質細胞群的特性。這種多功能性確保了其作為醫學領域診斷和後續觀察白血病、淋巴瘤和自體免疫疾病等疾病的基礎工具以及生命科學研究的關鍵手段，擁有持續的需求。

某些疾病日益加重的全球負擔是推動市場擴張的主要因素。流式細胞技術在愛滋病毒的防治和研究中發揮關鍵作用，它常與聚合酶鍊式反應（PCR）聯用，用於病毒分型和定量。同樣，其在腫瘤學領域用於癌症分類和監測的應用也持續推動市場需求。此外，該技術對於診斷和研究影響全球數百萬人的多種原發性和續發性免疫力缺乏至關重要，這些疾病通常需要先進的細胞分析技術才能進行適當的特性分析和治療。

大規模研究舉措和政府資助正在加速市場發展。旨在降低愛滋病毒感染率的公共衛生目標以及對幹細胞和再生醫學研究的大量津貼，為先進分析技術的應用創造了有利環境。這些措施通常直接資助流式細胞技術的基礎設施和耗材。同時，技術創新，特別是樣品製備和系統操作自動化的趨勢，正在推動效率的提高、工作流程的標準化和可重複性的增強。這種發展使得該技術在更廣泛的實驗室環境中更易於使用且更可靠。

該市場為成熟企業和新參與企業都提供了巨大的機會。持續的技術進步，以及政府支持的旨在促進技術應用和提供生物製造領域專業培訓的項目，正在降低准入門檻。這些發展使得新參與企業能夠透過專注於滿足日益成長的標準化、合規分析工具需求的專業應用、服務或創新產品特性來進入市場。

從區域來看，北美預計將實現顯著成長並保持其領先的市場佔有率。這一主導地位歸功於該地區愛滋病和癌症等重大疾病的高發生率、強大且技術先進的醫療保健基礎設施以及巨額的醫療保健支出。主要市場參與者的存在和濃厚的生物醫學研究氛圍進一步鞏固了該地區的領先地位，推動了流式細胞技術在診斷中心和研究實驗室中的應用。

競爭格局既包括Apogee Flow Systems等專業公司，也包括Bio-Rad Laboratories和Sysmex Corporation等多元化的全球領導者。這些公司致力於開發綜合解決方案，產品範圍涵蓋高效能的特定應用型細胞儀，以及專為臨床診斷環境設計的全自動整合系統。一個關鍵的行業趨勢是擴大利用軟體功能來確保資料完整性並符合生產規範。這反映了市場的成熟度以及受法規環境下對可靠、標準化數據日益成長的需求。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2021-2025 年）和預測資料（2026-2031 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 依產品類型流式細胞技術市場

  • 介紹
  • 裝置
  • 試劑

第6章 依技術分類的流式細胞技術市場

  • 介紹
  • 雷射基座
  • 電阻法

第7章流式細胞技術市場依應用領域分類

  • 介紹
  • 分子生物學
  • 病理
  • 免疫學
  • 其他

第8章 依最終用戶分類的流式細胞技術市場

  • 介紹
  • 醫院和診所
  • 學術和研究機構
  • 其他

第9章流式細胞技術市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 台灣
    • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第11章：公司簡介

  • Danaher Corporation
  • Becton Dickinson and Company
  • Sysmex Corp.
  • Agilent Technologies, Inc.
  • Apogee Flow Systems Ltd.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Stratedigm, Inc.
  • Miltenyi Biotec
  • Diasorin

第12章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061615577

The flow cytometry market, at a 7.34% CAGR, is projected to increase from USD 6.196 billion in 2025 to USD 9.479 billion in 2031.

The flow cytometry market is experiencing significant expansion, driven by its critical role in both clinical diagnostics and advanced research. This technology, which enables the rapid analysis of single cells to measure physical and chemical characteristics, has become indispensable for applications ranging from immunophenotyping to cell sorting. The market's growth is propelled by the increasing prevalence of specific diseases, continuous technological advancements, and substantial support from governmental and research institutions.

A primary driver of market growth is the extensive and diverse application portfolio of flow cytometry. The technology is utilized for analyzing a wide variety of specimens, including bone marrow, whole blood, and solid tissues. Its capabilities extend to immunophenotyping, DNA/RNA content analysis via fluorescent dyes, and the characterization of heterogeneous cell populations. This versatility makes it a cornerstone tool in healthcare for diagnosing and monitoring conditions such as leukemia, lymphoma, and autoimmune disorders, as well as a vital instrument in life sciences research, thereby ensuring sustained demand.

The rising global burden of specific diseases is a major factor bolstering market expansion. Flow cytometry plays an essential role in the management and study of HIV, where it is used in conjunction with PCR for viral subtyping and quantification. Similarly, its application in oncology for cancer classification and monitoring continues to be a significant demand driver. Furthermore, the technology is crucial for diagnosing and researching a wide spectrum of primary and secondary immunodeficiency disorders, conditions that affect millions worldwide and often require sophisticated cellular analysis for proper characterization and management.

Substantial research initiatives and government funding are accelerating market development. Public health goals aimed at reducing HIV incidence and significant grants for stem cell and regenerative medicine research create a favorable environment for the adoption of advanced analytical technologies. These initiatives often directly fund the infrastructure and consumables that drive flow cytometry usage. Concurrently, technological innovation, particularly the trend toward automation in sample preparation and system operation, is enhancing efficiency, standardizing workflows, and improving reproducibility. This evolution makes the technology more accessible and reliable for a broader range of laboratory settings.

The market presents considerable opportunities for both established players and new entrants. Ongoing technological advancements, coupled with government-backed programs that encourage technology adoption in biomanufacturing and provide specialized training, are lowering barriers to entry. These developments enable new participants to enter the market with a focus on specialized applications, services, or innovative product features that address the growing demand for standardized and compliant analytical tools.

Geographically, North America is expected to witness notable growth and maintain a significant market share. This leadership is attributed to the region's higher prevalence of key diseases such as HIV and cancer, a robust and technologically advanced healthcare infrastructure, and substantial healthcare expenditure. The presence of leading market players and a strong culture of biomedical research further consolidate the region's dominant position, driving the adoption of flow cytometry in both diagnostic centers and research institutions.

The competitive landscape includes specialized firms such as Apogee Flow Systems and diversified global leaders like Bio-Rad Laboratories and Sysmex Corp. These companies are focused on developing comprehensive solutions that range from high-performance cytometers for specific applications to fully automated, integrated systems designed for clinical diagnostic environments. A key industry trend is the enhancement of software capabilities to ensure data integrity and compliance with manufacturing guidelines, reflecting the market's maturation and the increasing need for reliable, standardized data in regulated environments.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Flow Cytometry Market Segmentation:

  • By Product Type
  • Instruments
  • Reagents
  • By Technology
  • Laser-Based
  • Impedance-Based
  • By Application
  • Molecular Biology
  • Pathology
  • Immunology
  • Others
  • By End-User
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. FLOW CYTOMETRY MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Instruments
  • 5.3. Reagents

6. FLOW CYTOMETRY MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Laser-Based
  • 6.3. Impedance-Based

7. FLOW CYTOMETRY MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Molecular Biology
  • 7.3. Pathlogy
  • 7.4. Immunology
  • 7.5. Others

8. FLOW CYTOMETRY MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Academic & Research Institutes
  • 8.4. Others

9. FLOW CYTOMETRY MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Danaher Corporation
  • 11.2. Becton Dickinson and Company
  • 11.3. Sysmex Corp.
  • 11.4. Agilent Technologies, Inc.
  • 11.5. Apogee Flow Systems Ltd.
  • 11.6. Bio-Rad Laboratories, Inc.
  • 11.7. Thermo Fisher Scientific, Inc.
  • 11.8. Stratedigm, Inc.
  • 11.9. Miltenyi Biotec
  • 11.10. Diasorin

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations